Blood-feeding parasites, including schistosomes, hookworms and malaria parasites, employ aspartic proteases to make initial or early cleavages in ingested host hemoglobin. To better understand the substrate affinity of these aspartic proteases, sequences were aligned with and/or three-dimensional, molecular models constructed of the cathepsin D-like aspartic proteases of schistosomes and hookworms, and of plasmepsins of Plasmodium falciparum and P. vivax, using the structure of human cathepsin D bound to the inhibitor pepstatin as the template. The catalytic subsites S5 through to S4' were determined for the modeled parasite proteases. Subsequently, the crystal structure of mouse renin complexed with the nonapeptidyl inhibitor t-butyl-CO-His-Pro-Phe-His-Leu [CHOHCH 2 ]Leu-Tyr-TyrSer-NH 2 (CH-66) was used to build homology models of the hemoglobin-degrading peptidases docked with a series of octapeptide substrates. The modeled octapeptides included representative sites in hemoglobin known to be cleaved by both Schistosoma japonicum cathepsin D and human cathepsin D, as well as sites cleaved by one but not the other of these enzymes. The peptidase-octapeptide substrate models revealed that differences in cleavage sites was generally attributable to the influence of a single amino acid change among the P5 to P4' residues that would either enhance or diminish the enzymatic affinity. The difference in cleavage sites appeared to be more profound than might be expected from sequence differences in the enzymes and hemoglobins. The findings support the notion that selective inhibitors of the hemoglobin-degrading peptidases of blood-feeding parasites at large could be developed as novel anti-parasitic agents.
INTRODUCTION
Blood flukes, hookworms, and the malaria parasites are among the most important pathogens of humans in terms of both numbers of people infected and the consequent morbidity and mortality (1) .
While phylogenetically unrelated, these parasites all share the same food source: they are obligate blood feeders, or hematophages. Hemoglobin (Hb) from ingested or parasitized erythrocytes is their major source of exogenous amino acids for growth, development and reproduction; the Hb, a ~64 kDa tetrameric polypeptide, is comprehensively catabolized by parasite enzymes to free amino acids or small peptides. Intriguingly, all these parasites appear to employ cathepsin D-like aspartic proteases to make initial or early cleavages in the Hb substrate (2-4).
The vertebrate endo-peptidase, cathepsin D (EC 3.4.23.5), is a member of the aspartic protease category of hydrolases, which also includes renin, pepsin, chymosin, cathepsin E, HIV protease and several other enzymes (5, 6) . Cathepsin D is expressed in a diverse range of mammalian cells and tissues, and is located predominantly in lysosomes (6) . The molecule comprises two rather similar lobes, each incorporating a homologous Asp-Thr-Gly catalytic site motif, with the substrate-binding groove located between these lobes. In aspartic proteases generally, the nucleophile that attacks the scissile bond of the substrate is an activated water molecule held in position by side chains of the two active-site aspartic acids (5) . Well-defined S4, S3, S2, S1, S1', S2', S3' and S4' subsite pockets for the amino acid side chains of the substrate (Ref. 5) are additional hallmarks of these enzymes. A peptide analogue of microbial origin, pepstatin, is the definitive, general inhibitor of aspartic proteases (7) . In general, human cathepsin D is specific for hydrophobic patches in proteins, with an ostensibly anomalous, additional preference for glutamate in the P2 position (8) (9) (10) (11) . 6 several other peptidases for which three dimensional homology models had been constructed. CH-66 is 2 ]Leu-Tyr-Tyr-Ser-NH 2 , and the complex of CH-66 within the active site groove of mouse renin is an informative example, with regard to the proteases and substrates targeted in this study, of an extended peptide (P5 to P4') analogue bound to an archetypal aspartic protease. It was anticipated that this complex would indicate subsite binding pockets in human cathepsin D and homologous aspartic proteases. Loop Search was used to replace the P1 and P1' isostere residues of the inhibitor with an extended dipeptide, and to assign coordinates to the P1 and P1' residues.
t-butyl-CO-His-Pro-Phe-His-Leu[CHOHCH
The core and key substrate binding-residues of mouse renin and human cathepsin D were superimposed using the alpha carbons, so that the peptidase and substrate models were in the same space coordinates to conserve the pattern of hydrogen bonding between the enzyme and the backbone peptide bonds of the substrate. For the mouse renin/CH-66 complex, the protease residues forming hydrogen bonds with the main chain of the inhibitor are Gly 37, His 79, Ser 80, Gly 81, Asp 220, Gly 222, Ser 219, Ser 222 and Thr 200, while Asp 35 and Asp 220 are the catalytic dyad of aspartic acids (numbering according to Fig. 1 ) (13) . Notably, these are consistent with the hydrogen bonding between human renin and the inhibitor CP-85339 (13) . The backbone atoms of human cathepsin D and mouse renin are not completely identical; differences in the conformations have been noted for the S3, S2' and S3' pockets (12, 13) . These differences produce renin subsite pockets that are less open, giving rise to the narrow specificity of this enzyme. Renin also has a higher degree of secondary structure, with some longer stretches of α-helix and β-sheet. Nonetheless, the appropriate pair of enzyme and substrate was associated as an assembly, and minimized with only atoms in the side-chains remaining unfixed. In some cases, the correct rotamer for the side chain of the substrate residue had to be selected empirically to avoid major clashes with the enzyme. As a result, the substrate models were effectively docked with the peptidase models.
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Amino acid sequence alignments Sequence alignments of the mature regions of the peptidases were prepared using Insight II software from MSI, and empirically refined by hand. Subsequently, in order to accommodate different colors, the alignment presented here was prepared using MacVector 6.5.3 software (Oxford Molecular) and edited manually to replicate the structural alignment generated with Insight II.
Modeled substrates Homology models were constructed of aspartic proteases complexed with the peptides KPIEF*FRL, FLSF*PTTK, LVTL*AAHL, and LDKF*LASV (where * represents the characterized or predicted scissile bond). FLSFPTTK, LVTLAAHL, and LDKFLASV are octapeptides found in a-chain of human Hb, as residues 33 to 40, 107 to114, and 126 to 133, respectively. KPIEFFRL is a synthetic peptide known to be a high affinity substrate for human cathepsin D (23) . Figure 1 presents the sequence alignments of the deduced mature enzyme amino-acid sequence of A. caninum cathepsin D-like protease, human cathepsin D, S. japonicum cathepsin D, S. mansoni cathepsin D, P. falciparum plasmepsin I, plasmepsin II, and mouse renin. The three-dimensional structures of human cathepsin D, plasmepsin II and mouse renin have been determined previously (12, 13, 24, 25) . The sequence alignment was based firstly on structural alignment, with residues found in consensus regions of secondary structure (α-helix, β-sheet) in human cathepsin D, P. falciparum plasmepsin II and mouse renin underlined. The remaining sequences were aligned taking into account the positions of conserved Cys, Gly, and Pro residues, as well as aromatic and hydrophobic residues in SCRs. The approximately 30 residues that constitute each subsite of the various cathepsin D-like, Hb-degrading peptidases, including P. vivax plasmepsin (1QS8) are listed in by guest on http://www.jbc.org/ Downloaded from Table 1 , illustrating not only the overall conservation of these residues, but also subsite differences among these peptidases. The allocation of residues to the pockets differs somewhat from others previously reported, particularly with respect to the S3' and S4' subsites (8, 9, 12, 13) , since it was assumed that the conformation of the inhibitor-complexed enzyme mimics that of its substrate-bound form. Profiles 3D analysis (22) of the molecular models indicated a high probability of correct folding, with very few residues defined as being misfolded (not shown).
RESULTS

Substrate subsite binding pockets
Cleavage of hemoglobin The cleavage of mammalian Hb by human cathepsin D has been reported recently (11) , as have the cleavage sites in human Hb for cathepsins D of S. japonicum and S. mansoni (4) . Hydrolysis of Hb by S. japonicum cathepsin D involves a generally discrete set of cleavages for the α-chain, compared with cleavage sites for human cathepsin D, whereas these two enzymes share most of the same cleavage points for the β-chain (Fig. 2) (4,11) . The orthologous sequences at these known cathepsin D cleavage sites for bovine, human and canine Hb are also listed in Figure 2 , although this does not imply that those sites indicated for other substrate species will be cleavage sites for that particular enzyme in every case. This scheme does not reflect the relative importance of each cleavage site or their order. Further, some sites in the Hb α-chain are adjacent, including Leu105*Leu106, Thr108*Leu109 and Leu109*Ala110; cleavage at any one of these would probably obviate cleavage at the vicinal sites. Perhaps the most striking of all these cathepsin D cleavage sites is FLSF*PTTK (residues 33-40 of the human Hb α-chain), for schistosomal enzyme (4), since a substrate with a proline residue at P1' appears to be rare or even unique for a eukaryotic aspartic protease.
Molecular models
Each of the protease and protease-substrate complex models minimized to a plausible structure with no significant defects. However, for reasons of brevity and clarity, much of the analysis and discussion presented here focus on the cathepsin D-like protease from S. japonicum.
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Profiles 3D analysis (19) of the model of this enzyme gave a value of 151, compared with an overall self-compatibility score of 151 and a lowest possible score of 68. This is a high figure, indicating a high probability that the model is correct. The only site of possible misfolding is the loop 46-54, which is well clear of the substrate-binding cleft. Figure 3 
Model of S. japonicum cathepsin D with FLSFPTTK at its active site cleft FLSFPTTK represents
residues 33 to 40 of the a-chain of human Hb. As with LDKFLASV (above), it is a cleavage site for schistosome but not human cathepsin D (Fig. 2) . Again, this is an unusual cleavage site, in that a PI' Pro represents an ostensibly rare substrate preference for a eukaryotic aspartic peptidase. As shown in The Thr P2' makes weak contacts with Ser 36, but is mostly solvent exposed. The Thr at P3' contacts Ile 217 and Tyr 194, but would not contact Ile 217 if the P1' residue were larger. The Lys at P4' is mostly solvent exposed, but has some hydrophobic contact with Leu 131 (Fig. 4, panel D ). An additional feature is noteworthy, if enigmatic: the conformation of Arg 77 of the S2' pocket (Table 1) differs in each of the three S. japonicum cathepsin D models presented here (Fig. 4, pocket, which would accommodate the binding by large hydrophobic residues such as Phe. It would also allow binding by hydrophilic and charged residues, such as Glu, although this is not evident from the known Hb cleavage sites (2). However, the P. falciparum plasmepsins I and II and the P. vivax plasmepsin all retain a Ser equivalent to Ser 80 of human cathepsin D (Table 1) , which suggests that they would have a similar P2 specificity for Glu residues. Another similarity with the human enzyme is (Table   1) , which would prevent plasmepsin I from cleaving FLSFPTTK (not shown), a site cleaved by the schistosome cathepsins D (Fig. 2; Fig. 4D ) but not by the human cathepsin D or P. falciparum plasmepsins I and II (2, 11) .
DISCUSSION
Hemoglobin-degrading enzymes of hematophagous parasites are being targeted for the rational development of novel anti-parasitic compounds (26, 27) . Given that Hb is the natural substrate of these enzymes, comparison of their cleavage sites in the molecule with the cleavage site profile of homologous mammalian-host enzymes, such as human cathepsin D, is likely to provide specific leads that could be exploited in inhibitor design. However, information on the Hb-cleavage patterns for human schistosomes has not been available until recently. Accordingly, by focusing here on the specific substrate cleavage patterns known for schistosome cathepsin D (4) and human cathepsin D (11), we undertook a molecular modeling analysis of some representative shared and discrete cleavage sites.
This involved the docking of octapeptides representing the P4 -P4' residues of Hb cleavage sites that were either common to both schistosome and human cathepsins D, or cleaved by one but not the other.
Using the crystal structures of human cathepsin D complexed with pepstatin and mouse renin complexed with CH-66, as guides for the models, approximately 30 residues could be identified as major contributors to substrate or inhibitor binding in the panel of target parasite and mammalian aspartic proteases (Table 1) . Eight of these catalytic subsite residues differed between human and S. japonicum cathepsins D. Such an ostensibly minor difference between these two enzymes raised the question as to why they do not cleave the α-and β-chains of Hb at exactly the same sites: of the 13 cleavage sites reported for both the mammalian (11) and S. japonicum cathepsin D (4), only six are shared (Fig. 2) . As depicted in Figure 4 144, and exhibits a preference for Lys, Arg, Glu, or His at P2'. As with the S3 subsite, this pocket should accommodate hydrophobic and hydrophilic side chains, although P2' hydrophobics are not common (8) (9) (10) (11) . These models suggest that the functional ends of long basic P2' residues (Lys and Arg) are mostly exposed to the solvent, but that shorter hydrophilic side chains, such as those of Glu and It is clear that the differences in Hb cleavage by the proteases examined here reflect subtle yet significant differences in their substrate binding pockets. Development of selective inhibitors of these parasite aspartic proteases, as novel anti-infective agents, will depend on defining these differences, and deriving compounds that exploit one or (preferably) several of them. From an evolutionary perspective, it is straightforward to conceptualize how mutations in Hb genes would lead to amino acid substitutions in their products, and how the cumulative effect of such substitutions could then reduce the efficiency of the hematophagous parasite's cognate hemoglobinases, delivering a selective advantage to the host by reducing the viability or virulence of the parasite. Moreover, as speculated previously (31) , the compatibility between a parasite's Hb-degrading enzymes and the Hb of its mammalian hosts (Fig. 2) is likely to be a critical factor in determining its host range, i.e. host-specificity. In this regard, it is notable that plasmepsin II has a lower affinity for fetal than for adult Hb, which contributes to the innate resistance of human neonates to malaria (32) . by guest on 
